Literature DB >> 21278629

Nuclei pulposi formation from the embryonic notochord occurs normally in GDF-5-deficient mice.

Jennifer A Maier1, Brian D Harfe.   

Abstract

STUDY
DESIGN: The transition of the mouse embryonic notochord into nuclei pulposi was determined ("fate mapped") in vivo in growth and differentiating factor-5 (GDF-5)-null mice using the Shhcre and R26R alleles.
OBJECTIVE: To determine whether abnormal nuclei pulposi formation from the embryonic notochord was responsible for defects present in adult nuclei pulposi of Gdf-5-null mice. SUMMARY OF BACKGROUND DATA: The development, maintenance, and degeneration of the intervertebral disc are not understood. Previously, we demonstrated that all cells in the adult nucleus pulposus of normal mice are derived from the embryonic notochord. Gdf-5-null mice have been reported to contain intervertebral discs in which the nucleus pulposus is abnormal. It is currently unclear if disc defects in Gdf-5-null mice arise during the formation of nuclei pulposi from the notochord during embryogenesis or result from progressive postnatal degeneration of nuclei pulposi.
METHODS: Gdf-5 messenger RNA expression was examined in the discs of wild-type embryos by RNA in situ hybridization to determine when and where this gene was expressed. To examine nucleus pulposus formation in Gdf-5-null mice, intervertebral discs in which embryonic notochord cells were marked were analyzed in newborn and 24-week-old mice.
RESULTS: Our Gdf-5 messenger RNA in situ experiments determined that this gene is localized to the annulus fibrosus and not the nucleus pulposus in mouse embryos. Notochord fate-mapping experiments revealed that notochord cells in Gdf-5-null mice correctly form nuclei pulposi.
CONCLUSION: Our data suggest that the defects reported in the nucleus pulposus of adult Gdf-5-null mice do not result from abnormal patterning of the embryonic notochord. The use of mouse alleles to mark cells that produce all cell types that reside in the adult nucleus pulposus will allow for a detailed examination of disc formation in other mouse mutants that have been reported to contain disc defects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278629      PMCID: PMC3107355          DOI: 10.1097/BRS.0b013e318210eec4

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  29 in total

Review 1.  Anatomy and examination of the spine.

Authors:  Michael W Devereaux
Journal:  Neurol Clin       Date:  2007-05       Impact factor: 3.806

2.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

3.  GDF5 coordinates bone and joint formation during digit development.

Authors:  E E Storm; D M Kingsley
Journal:  Dev Biol       Date:  1999-05-01       Impact factor: 3.582

Review 4.  Lumbar disc disorders and low-back pain: socioeconomic factors and consequences.

Authors:  Jeffrey N Katz
Journal:  J Bone Joint Surg Am       Date:  2006-04       Impact factor: 5.284

5.  Mutations in CDMP1 cause autosomal dominant brachydactyly type C.

Authors:  A Polinkovsky; N H Robin; J T Thomas; M Irons; A Lynn; F R Goodman; W Reardon; S G Kant; H G Brunner; I van der Burgt; D Chitayat; J McGaughran; D Donnai; F P Luyten; M L Warman
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

6.  Effects of growth differentiation factor-5 on the intervertebral disc--in vitro bovine study and in vivo rabbit disc degeneration model study.

Authors:  Takehide Chujo; Howard S An; Koji Akeda; Kei Miyamoto; Carol Muehleman; Mohamed Attawia; Gunnar Andersson; Koichi Masuda
Journal:  Spine (Phila Pa 1976)       Date:  2006-12-01       Impact factor: 3.468

7.  Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.

Authors:  S Vujovic; S Henderson; N Presneau; E Odell; T S Jacques; R Tirabosco; C Boshoff; A M Flanagan
Journal:  J Pathol       Date:  2006-06       Impact factor: 7.996

8.  Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling.

Authors:  L C Murtaugh; J H Chyung; A B Lassar
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

9.  Mechanisms of GDF-5 action during skeletal development.

Authors:  P H Francis-West; A Abdelfattah; P Chen; C Allen; J Parish; R Ladher; S Allen; S MacPherson; F P Luyten; C W Archer
Journal:  Development       Date:  1999-03       Impact factor: 6.868

10.  Transcriptional profiling of the nucleus pulposus: say yes to notochord.

Authors:  Irving M Shapiro; Makarand V Risbud
Journal:  Arthritis Res Ther       Date:  2010-05-20       Impact factor: 5.156

View more
  5 in total

1.  Neonatal annulus fibrosus regeneration occurs via recruitment and proliferation of Scleraxis-lineage cells.

Authors:  Olivia M Torre; Victoria Mroz; Anthony R Martinez Benitez; Alice H Huang; James C Iatridis
Journal:  NPJ Regen Med       Date:  2019-12-20

2.  Role of growth differentiation factor-5 and bone morphogenetic protein type II receptor in the development of lumbar intervertebral disc degeneration.

Authors:  Yi-Fan Li; Xian-Zhong Tang; Chao-Ge Liang; Yao-Ming Hui; Yun-Han Ji; Wei Xu; WenJun Qiu; Li-Ming Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 3.  Signaling networks in joint development.

Authors:  Joanna E Salva; Amy E Merrill
Journal:  Dev Dyn       Date:  2016-12-29       Impact factor: 3.780

4.  Association of GDF-5 rs143383 polymorphism with radiographic defined knee osteoarthritis: A systematic review and meta-analysis.

Authors:  Kazem Aghili; Mohammad Reza Sobhan; Masoud Mehdinezhad-Yazdi; Mohammadali Jafari; Seyed Mohsen Miresmaeili; Shohreh Rastegar; Mahta Mazaheri; Hossein Neamatzadeh
Journal:  J Orthop       Date:  2018-08-24

5.  Neonatal annulus fibrosus regeneration occurs via recruitment and proliferation of Scleraxis-lineage cells.

Authors:  Olivia M Torre; Victoria Mroz; Anthony R Martinez Benitez; Alice H Huang; James C Iatridis
Journal:  NPJ Regen Med       Date:  2019-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.